Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rosaria Rizzo

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Oxidative Medicine and Cellular Longevity|December 4, 2020
Cardioprotective Effects of Taurisolo® in Cardiomyoblast H9c2 Cells under High-Glucose and Trimethylamine N-Oxide Treatment <i>via De Novo</i> Sphingolipid SynthesisStefania Lama, Vincenzo Monda, Maria Rosaria Rizzo, et al.
Pharmacological Research|January 12, 2022
Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatmentMaria Rosaria Rizzo, Irene Di Meo, Rita Polito, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 13, 2023
Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journeyConcetta Irace, Sara Coluzzi, Graziano Di Cianni, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 22, 2020
Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complicationsLucia Scisciola, Maria Rosaria Rizzo, Vittoria Cataldo, et al.
Atherosclerosis|February 19, 2002
Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenariansMaria Rosaria Rizzo, Emilia Ragno, Michelangela Barbieri, et al.
Plos One|December 22, 2017
Serum adiponectin levels are associated with worse cognitive function in postmenopausal womenPasquale De Franciscis, Michelangela Barbieri, Stefania Leo, et al.
Cardiovascular Diabetology|June 11, 2017
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomesCelestino Sardu, Michelangela Barbieri, Matteo Santamaria, et al.
Journal of the American College of Cardiology|April 18, 2009
Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patientsRaffaele Marfella, Clara Di Filippo, Michele Portoghese, et al.
Journal of the American College of Cardiology|May 21, 2013
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patientsRaffaele Marfella, Ferdinando Carlo Sasso, Mario Siniscalchi, et al.
Oxidative Medicine and Cellular Longevity|July 3, 2014
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot studyPaola Stiuso, Ilaria Scognamiglio, Marianna Murolo, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Oxidative Medicine and Cellular Longevity|December 4, 2020
Cardioprotective Effects of Taurisolo® in Cardiomyoblast H9c2 Cells under High-Glucose and Trimethylamine N-Oxide Treatment <i>via De Novo</i> Sphingolipid SynthesisStefania Lama, Vincenzo Monda, Maria Rosaria Rizzo, et al.
Pharmacological Research|January 12, 2022
Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatmentMaria Rosaria Rizzo, Irene Di Meo, Rita Polito, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 13, 2023
Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journeyConcetta Irace, Sara Coluzzi, Graziano Di Cianni, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 22, 2020
Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complicationsLucia Scisciola, Maria Rosaria Rizzo, Vittoria Cataldo, et al.
Atherosclerosis|February 19, 2002
Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenariansMaria Rosaria Rizzo, Emilia Ragno, Michelangela Barbieri, et al.
Plos One|December 22, 2017
Serum adiponectin levels are associated with worse cognitive function in postmenopausal womenPasquale De Franciscis, Michelangela Barbieri, Stefania Leo, et al.
Cardiovascular Diabetology|June 11, 2017
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomesCelestino Sardu, Michelangela Barbieri, Matteo Santamaria, et al.
Journal of the American College of Cardiology|April 18, 2009
Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patientsRaffaele Marfella, Clara Di Filippo, Michele Portoghese, et al.
Journal of the American College of Cardiology|May 21, 2013
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patientsRaffaele Marfella, Ferdinando Carlo Sasso, Mario Siniscalchi, et al.
Oxidative Medicine and Cellular Longevity|July 3, 2014
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot studyPaola Stiuso, Ilaria Scognamiglio, Marianna Murolo, et al.
Pageof 10